Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacodynamics of 3.0mg LNG in Obese Women
NCT02863445Phase 4Completed
- Sponsor
- Oregon Health & Science University
- Start
- Jul 2017
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of avatrombopag in unintended pregnancy (2 arms), sponsored by Oregon Health & Science University. Primary endpoint: Number of Participants With no Follicle Rupture at 5 Days Within One Menstrual (Treatment) Cycle. Started Jul 2017; status: completed.
02
Drugs
avatrombopag
03
Conditions
unintended pregnancy
Beyond the preview
Go deeper on NCT02863445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02863445.